API reference

Luliconazole

CAS number
187164-19-8
Molecular formula
C14H9Cl2N3S2
Molecular weight
354.3 g/mol
Luliconazole — 2D structure
2D structure (PubChem)

About this molecule

Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan.

Source: DrugBank, via PubChem.

Identifiers

IUPAC name
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile
InChIKey
YTAOBBFIOAEMLL-REQDGWNSSA-N
SMILES
C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl
PubChem CID
3003141

Also known as

Luliconazole · Lulicon · Luzu · NND-502 · luliconazol · Lulifin · NND502 · luliconazolum

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com